Soluble and Endogenous Secretory Receptors for Advanced Glycation End Products in Threatened Preterm Labor and Preterm Premature Rupture of Fetal Membranes

Table 4

Descriptive statistics of studies groups by ANOVA Kruskall-Wallis comparison.

Parameters	Group A					Group B					Group C
		min–max			Me		min–max			Me		min–max			Me
Age years	41	15–41	24	32	30	49	16–41	26	35	31	48	17–40	25	33	29	NS
WBC G/L	41	3,3–20,0	9,51	14,4	13,19	49	8,2–25,4	10,05	14,38	11,82	48	8,0–21,0	9,97	14,04	11,43	NS
CRP mg/L	41	0,4–39,5	2,3	5,5	3,7	49	0,2–77,3	2,7	11,8	5,8	48	0,3–19,0	1,5	5,4	3,7	NS
Band %	41	63–92	74,2	79,4	76,8	49	55–91	66,7	80,8	71,7	48	60–91	66,9	79,8	73,0	NS
sRAGE pg/mL	41	128–1686	352	787	594	49	48–4872	297	775	612	48	77–1787	285	887	714	NS
esRAGE pg/mL	41	230–915	406	533	490	49	281–958	483	610	541	48	410–1096	497	613	542	0,00

WBC: white blood cells.
CRP: C-reactive protein serum level.
Band: banded neutrophils.
sRAGE: secretory receptors for advanced glycation end products.
esRAGE: endogenous secretory receptors for advanced glycation end products.
: Quartile 1.
: Quartile 3.
Me: median.
: level of significance.